Twist Bioscience Corp
F:0ME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Twist Bioscience Corp
F:0ME
|
US |
|
W
|
Webjet Ltd
OTC:WEBJF
|
AU |
|
Petmed Express Inc
NASDAQ:PETS
|
US |
|
Wallenius Wilhelmsen ASA
OSE:WAWI
|
NO |
|
M
|
Major Drilling Group International Inc
OTC:MJDLF
|
CA |
|
Societe BIC SA
F:BIF0
|
FR |
|
I
|
Iluka Resources Ltd
OTC:ILKAY
|
AU |
|
T
|
Tejon Ranch Co
F:2TJ
|
US |
|
Jyske Bank A/S
F:JYS
|
DK |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
DUS:MUV2
|
DE |
|
A
|
Ares Commercial Real Estate Corp
F:41I
|
US |
|
D
|
DBA Group SpA
MIL:DBA
|
IT |
|
M
|
Mitek Systems Inc
F:MKQ
|
US |
|
L B Foster Co
NASDAQ:FSTR
|
US |
|
M
|
Match Group Inc
F:4MGN
|
US |
Wall St Price Targets
0ME Price Targets Summary
Twist Bioscience Corp
According to Wall Street analysts, the average 1-year price target for
0ME is 21.24 EUR with a low forecast of 16.11 EUR and a high forecast of 26.52 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0ME's stock price target?
Price Target
21.24
EUR
According to Wall Street analysts, the average 1-year price target for
0ME is 21.24 EUR with a low forecast of 16.11 EUR and a high forecast of 26.52 EUR.
What is the Revenue forecast for Twist Bioscience Corp?
Projected CAGR
18%
Over the last 8 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 6 years is 18%.
What is the Gross Profit forecast for Twist Bioscience Corp?
Projected CAGR
22%
The compound annual growth rate for Gross Profit over the next 6 years is 22%.